Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Walsh, Edward E., Frenck, Robert W., Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J., Bailey, Ruth, Swanson, Kena A., Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Tompkins, Kristin R., Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R., Jansen, Kathrin U., Şahin, Uğur, Gruber, William C.
Formato: Artigo
Idioma:Inglês
Publicado em: Massachusetts Medical Society 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583697/
https://ncbi.nlm.nih.gov/pubmed/33053279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2027906
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados